Co-encapsulation of bioengineered IGF-II-producing cells and pancreatic islets: effect on beta-cell survival.
about
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogelDelivering bioactive molecules as instructive cues to engineered tissues.From cell culture to a cure: pancreatic β-cell replacement strategies for diabetes mellitus.Encapsulated Islet Transplantation: Where Do We Stand?Applications of Cell Microencapsulation.
P2860
Co-encapsulation of bioengineered IGF-II-producing cells and pancreatic islets: effect on beta-cell survival.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@en
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@nl
type
label
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@en
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@nl
prefLabel
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@en
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@nl
P2093
P2860
P356
P1433
P1476
Co-encapsulation of bioenginee ...... effect on beta-cell survival.
@en
P2093
J Dusseault
L Rosenberg
P Y Benhamou
P2860
P2888
P304
P356
10.1038/GT.2010.166
P577
2011-01-13T00:00:00Z